Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Knopp Neurosciences has completed a series B funding round of $10 million, increasing its total capitalization to $20 million.
Subscribe to our email newsletter
The latest financing involved the exercise of milestone-based callable warrants held by existing investors in Knopp. The company anticipates making a further series B call of $10 million following the initiation of Phase II studies of KNS-760704 in amyotrophic lateral sclerosis.
Saturn Capital of Boston acted as exclusive placement agent for Knopp’s series A and series B financings.